Literature DB >> 7813269

Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease.

M L Render1, A S Weinstein, A S Blaustein.   

Abstract

OBJECTIVE: To evaluate the effectiveness of simple clinical variables and radionuclide ventriculogram in separating those patients with isolated chronic obstructive pulmonary disease (COPD) from those with COPD and coexisting left ventricular dysfunction (LVD).
DESIGN: Retrospective record review of 77 patients with increasing dyspnea, defined as recent deterioration in exercise tolerance, new use of corticosteroids, or recent hospital admission for COPD; referred to the outpatient Pulmonary Rehabilitation Program at the Cincinnati Veterans Affairs Medical Center from July 1987 to October 1992.
SETTING: Outpatient medical clinic. PATIENTS: Veterans who were referred to the Pulmonary Rehabilitation Program. MEASUREMENTS: History and physical findings, pulmonary function tests, arterial blood gases, distance achieved in a 12-min walk, dyspnea score, electrocardiogram, chest radiograph, and radionuclide multigated ventriculography.
RESULTS: Twenty-five of 77 patients evaluated in the Pulmonary Rehabilitation Program for increasing dyspnea were functionally more limited (12-min walk 10.4 vs 13.9 laps; MRC score 2.68 vs 2.06; p < 0.05) and had left ventricular dysfunction (LVD) (left ventricular ejection fraction < 40%) associated with wall motion abnormalities on radionuclide ventriculogram. Careful standard clinical evaluation did not separate those patients with COPD from those with both COPD and LVD.
CONCLUSIONS: LVD was found in 32% of patients with COPD presenting with symptomatic deterioration. Since the therapeutic approach to these two disorders differs, the identification of patients with LVD is important. Prospective studies are needed to identify the most cost-effective approach to this problem of coexisting disease and to evaluate the benefit from therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7813269     DOI: 10.1378/chest.107.1.162

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease.

Authors:  Christophe Baillard; Mohamed Boussarsar; Jean-Philippe Fosse; Emmanuelle Girou; Philippe Le Toumelin; Christophe Cracco; Samir Jaber; Yves Cohen; Laurent Brochard
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

2.  Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Authors:  Suellen M Curkendall; Stephan Lanes; Cynthia de Luise; Mary Rose Stang; Judith K Jones; Dewei She; Earl Goehring
Journal:  Eur J Epidemiol       Date:  2006-11-15       Impact factor: 8.082

Review 3.  How well can the chest radiograph diagnose left ventricular dysfunction?

Authors:  R G Badgett; C D Mulrow; P M Otto; G Ramírez
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

4.  Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease.

Authors:  N K Gupta; Ritesh Kumar Agrawal; A B Srivastav; M L Ved
Journal:  Lung India       Date:  2011-04

5.  How does Dirofilaria immitis infection impact the health of dogs referred to cardiology care.

Authors:  Nathália Marques De Oliveira Lemos; Bruno Alberigi; Norma Labarthe; Fabiana Batalha Knacfuss; Cristiane Divan Baldani; Marta Fernanda Albuquerque da Silva
Journal:  Braz J Vet Med       Date:  2022-09-20

Review 6.  The association between COPD and heart failure risk: a review.

Authors:  Javier de Miguel Díez; Jorge Chancafe Morgan; Rodrigo Jiménez García
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-06-28

7.  Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Koichi Nishimura; Takashi Nishimura; Katsuya Onishi; Toru Oga; Yoshinori Hasegawa; Paul W Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-05

Review 8.  [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis].

Authors:  Anna Serrano-Mollar
Journal:  Arch Bronconeumol       Date:  2012-10       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.